Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: September 14, 2004
On January 6 and 7, 2004, the Institute of Medicine (IOM) hosted the 1st Annual Crossing the Quality Chasm Summit, convening a diverse group of national and community health care leaders to pool their knowledge and resources with regard to strategies for improving patient care for five common chronic illnesses: asthma, depression, diabetes, heart failure, and pain control in advanced cancer.
Released: September 08, 2004
Since 1992, the Department of Defense (DOD), through the U.S. Army Medical Research and Material Command (USAMRMC), has received congressionally earmarked appropriations for programs of biomedical research on prostate, breast, and ovarian cancer, neurofibromatosis, tuberous sclerosis, and other health problems. At the request of Congress, the Institute of Medicine (IOM) examined possibilities of augmenting program funding from alternative sources. The resulting IOM report, Strategies to Leverage Research Funding: Guiding DOD's Peer Reviewed Medical Research Programs, focuses on nonfederal and private sector contributions that could extend the appropriated funds without biasing the peer review project selection process.
Released: August 26, 2004
To determine if entry into US Army service during periods of administration of SV40-contaminated adenovirus vaccine was associated with an increased risk of cancer, the authors conducted a case control study of cancer occurring in male Army veterans who entered service in 1959–1961.
Released: August 20, 2004
The Institute of Medicine (IOM) has been conducting a series of congressionally-mandated studies to examine the scientific and medical literature on the potential health effects of chemical and biological agents. In response to veterans' ongoing concerns and recent publications in the literature, IOM updated its reporton sarin exposure. In the report, Gulf War and Health: Updated Literature Review of Sarin, the committee concluded that there is still not enough evidence to determine whether exposure to low doses of sarin are associated with long-term health problems.
Released: August 19, 2004
The food packages designed to supplement the diets of low-income individuals through the USDA's Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) have remained largely unchanged since the program was started in 1974. As a first step toward determining if changes are needed to strengthen the nutritional quality of the WIC food packages, an IOM committee has evaluated the dietary intakes of the WIC-eligible population. The findings are summarized in the committee's preliminary report, Proposed Criteria For Selecting the WIC Food Packages.
Released: July 28, 2004
Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects assists policymakers in evaluating the appropriate scientific methods for detecting unintended changes in food and assessing the potential for adverse health effects from genetically modified products. In this report, the committee recommended that greater scrutiny should be given to foods containing new compounds or unusual amounts of naturally occurring substances, regardless of the method used to create them.
Released: July 27, 2004
Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance addresses the challenge of making effective antimalarial drugs widely accessible in order to reverse the current increasing trend in deaths from drug-resistant malaria. Because the newer drugs are more expensive than those that they are replacing, the affected populations--among the world's poorest--cannot afford them.
Released: July 07, 2004
An estimated forty million people carry the human immunodeficiency virus (HIV), and five million more become newly infected annually. In recent years, many HIV-infected patients in wealthy nations have eAffiliateMarketIngtoolsed significantly longer, good-quality lives as a result of antiretroviral therapy (ART). However, most infected individuals live in the poorest regions of the world, where ART is virtually nonexistent. The consequent death toll in these regions--especially sub-Saharan Africa--is begetting economic and social collapse. To inform the multiple efforts underway to deploy antiretroviral drugs in resource-poor settings, the Institute of Medicine committee was asked to conduct an independent review and assessment of rapid scale-up ART programs.
Released: July 06, 2004
In this report, the committee discusses some of the challenges and opportunities likely to arise as public health preparedness is being integrated into the broader field of emergency and disaster preparedne
Released: June 24, 2004
Children's health has clearly improved over the past several decades. Yet major questions still remain about how to assess the status of children's health, what factors should be monitored, and the appropriate measurement tools that should be used. Children's Health, The Nation's Wealth provides a detailed examination of the information about children's health that is needed to help policy makers and program providers at the federal, state, and local levels.